Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct-Dec;61(4):1077-1083.
doi: 10.47162/RJME.61.4.10.

Tissue microarrays - brief history, techniques and clinical future

Affiliations

Tissue microarrays - brief history, techniques and clinical future

Alina Elena Ştefan et al. Rom J Morphol Embryol. 2020 Oct-Dec.

Abstract

Introduction and aim: There is a growing need for better, cheaper and faster histopathological diagnostic. The authors reviewed the main steps of the efforts towards the improvement of the pre-analytical phase of tissue processing for histological examination.

Results: Since their introduction decades ago tissue microarrays (TMAs) proved their value by increasing efficiency, standardization and accuracy of many histological techniques, such as histochemistry, histoenzymology, immunohistochemistry, in situ hybridization, etc. By allowing the simultaneous analysis and comparison of multiple different tissues on a single histology slide (up to 1000 individual samples), TMAs are also having a significant economic advantage (consumables and labor). From its first description until recent years, the TMA techniques have evolved steadily but slowly despite many attempts to adapt it for clinical diagnostics. In this paper, we are reviewing the main techniques of obtaining TMA blocks from the beginning to the present day, as well as recent developments that are expanding their scope into high accuracy/efficiency clinical diagnostics.

Conclusions: Considering recent developments, we believe that the prospect of high-throughput histology might be achievable in the not-so-distant future.

PubMed Disclaimer

Conflict of interest statement

Alina Elena Ştefan, Daniela Gologan and Sorin Muşat are employed by LUMEA Inc., Lehi, Utah, USA, who are manufacturing BxChip™ (Patent US D836796 S, 2017).

Figures

Figure 1
Figure 1
Vegetal TMA – Muşat method: (A) Paraffin donor tissue sampling device; (B) Donor paraffin block; (C) Removing the donor tissue from the sampling device; (D) Empty vegetal tissue microarray and donor tissue samples of different sizes; (E) Loaded TMA block; (F) TMA section; (G) HE-stained slide of a vegetal TMA section. HE: Hematoxylin–Eosin; TMA: Tissue microarray.
Figure 2
Figure 2
BxChip™ TMA: (A and B) Loading the BxChip™ with biopsies; (C) Placing the BxChip™ in a histological cassette between two reticulated sponges; (D) BxChip™ paraffin block; (E) HE-stained slide of a BxChip™ section. HE: Hematoxylin–Eosin; TMA: Tissue microarray

References

    1. Bubendorf L, Nocito A, Moch H, Sauter G. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol. 2001;195(1):72–79. - PubMed
    1. Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet. 2001;10(7):657–662. - PubMed
    1. Sauter G. Representativity of TMA studies. Methods Mol Biol. 2010;664:27–35. - PubMed
    1. Tennstedt P, Sauter G. Quality aspects of TMA analysis. Methods Mol Biol. 2010;664:17–26. - PubMed
    1. Lillie RD. 3. New York: Blakiston Division, McGraw–Hill Book Company; 1965. Histopathologic technic and practical histochemistry.https://www.worldcat.org/title/histopathologic-technic-and-practical-his...